Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating, Announces Target Price $390
Truist Cuts Price Target on Stryker to $390 From $413, Keeps Hold Rating
Under the Deepseek effect, Goldman Sachs puts cold water on the Datacenter boom: the Global Datacenter utilization rate has reached its peak.
From the release of DeepSeek, which is a low-cost competitor to ChatGPT, to Microsoft scaling back its Global AI Datacenter projects, and Alibaba Director Zhang Yong warning about a bubble in USA AI infrastructure investments, multiple warning signals are flashing: the boom in AI Datacenters may soon be facing a cool down.
Trending Industry Today: Tempus AI Leads Losses In AI Medical Concept Stocks
Pharma, MedTech Stocks Bounce Back as Trump Pauses Most Tariffs
What Does the Market Think About Stryker?
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings?
Is Weakness In Stryker Corporation (NYSE:SYK) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Stryker to Announce Financial Results for Its First Quarter of Fiscal Year 2025
Express News | Stryker Corp : Citigroup Cuts Target Price to $443 From $450
Express News | UFP Technologies: Deal Contemplates Investments by Both Parties & Commitment by Co to Transfer Manufacturing Over Next 2 Years to Dominican Republic
Express News | UFP Technologies - Stryker to Buy 100% of Requirements for Some Products From Co for 42 Months Starting Jan 1, 2026 - SEC Filing
Unusual Options Activity: CCJ, ROKU and Others Attract Market Bets, CCJ V/OI Ratio Reaches 308.6
U.S. Stocks Poised for Earnings Surprises in April
Trending Industry Today: GE HealthCare Technologies Leads Losses In AI Medical Concept Stocks
Stryker, Boston Scientific Down as New Tariffs Impact Medtech Industry
Express News | Shares of US Medical Device Maker Extend Declines to Fall Between 5% and 9%
Express News | Insulet and Dexcom Shares Down 5% Each, GE Healthcare, Boston Scientific and Stryker Shares Fall 3% Each
Express News | Shares of Some US Medical Device Makers Down Between 3% and 5.5% After Trump's Reciprocal Tariffs
CCORF Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $435